Oligodendrocyte breakdown: a driving force in Alzheimer’s?
The diversity of non-drug-based interventions against dementia
Clinical trial for BAN2401 in early Alzheimer’s: combining ADCOMS and Bayesian statistics
MRI and PET scans: what can we measure in Alzheimer’s patients?
Plasma tau levels and Alzheimer’s disease: what’s the relationship?